Zydus Cadila seeks Phase 3 clinical trials approval for its Covid-19 vaccine 0 24.12.2020 09:50 HindustanTimes.com The trial has been reviewed by an independent Data Safety Monitoring Board (DSMB), and reports have been submitted to Central Drugs Standard Control Organisation (CDSCO) regularly for the update on safety outcome. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
